REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact
News
ENEA presented REPRODIVAC to ASSOSUINI
ENEA presented the REPRODIVAC project to a number of members of the Assosuini association, one of the organisations involved in the project. It provided an opportunity to outline the project and discuss with them which diseases have the greatest impact on pig farms and therefore require the most urgent solutions in terms of diagnosis and research into new vaccines. At the top of the list of pathogens of greatest concern to pig farms is PRRSV
REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.
REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.